SEC Company Response from NEW WORLD BRANDS INC (CIK 0000799426) — May 3, 2005
NEW WORLD BRANDS INC (CIK 0000799426)
Date: May 3, 2005 · CIK: 0000799426 · Accession: 0001161697-05-000427
AI Filing Summary & Sentiment
Referenced dates: March 22, 2005, March 22, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
NEW WORLD BRANDS, INC.
2019 SW 20 Street
Suite 109
Fort Lauderdale, Florida 33315
Telephone (954) 713-0222
Fax (954) 713-0354
April 29, 2005
Mr. George F. Ohsiek, Jr.
Staff Accountant
U.S. Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
RE: New World Brands, Inc.
Form 10-KSB for the fiscal year ended May 31, 2004
File Date: August 30, 2004
File No. 033-91432
Dear Mr. Ohsiek:
This letter will respond to your letter dated March 22, 2005.
1. The undersigned, on behalf of New World Brands, Inc. (the "Company")
acknowledges the following:
a. The Company is responsible for the adequacy and accuracy of
the disclosures in the filing.
b. Staff comments or changes to disclosure in response to staff
comments do not foreclose the U.S. Securities and Exchange
Commission (the "Commission") from taking any action with
respect to the filing.
c. The Company may not assert this action as a defense of any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
2. As we discussed, the equity transactions were private sales of stock
made to thirteen investors simultaneously and on the same terms. The
terms indicate fair value to a willing buyer and willing seller. Dr.
Passen became Chairman of the Board after the consummation of the
transaction. At the time of the execution of the agreement in
connection with the equity infusion, it was not contemplated that Dr.
Passen would become Chairman of the Board. However, after the agreement
was signed and after the terms of the deal were negotiated, Dr. Passen
felt it was appropriate for him to become a member of the Board of
Directors in order to monitor his investment. No additional services by
Dr. Passen were expected by the Company and no employment agreement was
executed. Dr. Passen only serves as Chairman of the Board. He does not
hold a position as an officer. Dr. Passen does not devote his full time
and attention to the Company. Rather, Dr.
<PAGE>
Mr. George F. Ohsiek, Jr.
April 29, 2005
Page 2
Passen only devotes a portion of his time to the affairs of the
Company. For the most part his involvement is merely designed to
monitor his investment. Pursuant to your request, attached you will
find copies of board minutes leading up to and immediately following
the equity issuance including documentation regarding the appointment
of Dr. Passen as Chairman.
3. As we discussed in our telephone conversation, many alcohol brands,
assuming they are marketed properly and develop a solid reputation,
contribute to cash flows into the indefinite future. Jack Daniels has
been generating cash flow for over 134 years. This brand continues to
experience double digit gains in various markets. The world famous
Bacardi Rum was created in 1862, 143 years ago, and continues to enjoy
great success through its classic Bacardi Carta Blanca, and other
variations including Bacardi Limon, Bacardi O aand Bacardi Gold.
Because these and other spirit products generally have an indefinite
useful life, as accepted brand loyalty carries on over the years, the
Company originally treated the intangible relating to Xtreme Delight
Cocktails as indefinite-lived. However, in March 2005 the Company
entered into an agreement with Maple Leaf Distillers, Inc. ("MLD") to
jointly market and promote a ready-to-drink cocktail called Norm's
Extreme Cocktails. As a result, commencing in March 2005, the Company
revised its financial statements to treat this intangible as a
finite-lived intangible asset.
4. Since the Company acquired the formulas and packaging for Xtreme
Delight Cocktails in May 2003, management determined this intangible
asset to have its original value. The Company based this on projected
cash flows, including but not limited to cash flow generated from the
agreement entered into January of 2004 granting exclusive rights to
market and sell the product in Honduras. Moreover, in May 2004, the
Company received an equity infusion of $1.7 million dollars based, at
least part, on the perceived value of the Xtreme Delight Cocktails
intangible asset. Notwithstanding the foregoing, in light of the
Company's agreement with MLD and determination to jointly market and
promote Norm's Extreme Cocktails instead of Xtreme Delight Cocktails,
in March 2005, the Company agreed to reduce the value of this
intangible asset to zero. The Company's most recent financial
statements reflect this valuation.
We trust the foregoing is responsive to your letter dated March 22,
2005. However, if you should have any questions or require any additional
information or documentation, please contact the undersigned.
Sincerely yours,
/s/ Costas Ataliotis
Costas Ataliotis
Chief Executive Officer
</TEXT>
</DOCUMENT>